Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.
The stablecoin giant invests in AI-powered sleep technology company Eight Sleep, extending a biotech investment strategy that began with its $200 million majority stake in Blackrock Neurotech.
China announces accelerated brain-computer interface development strategy, positioning itself as a direct competitor to US dominance in the neurotechnology sector.
New framework resolves the historic trade-off between acoustic richness and linguistic clarity in neural speech decoding, achieving 4.0/5.0 intelligibility with minimal training data.
Max Hodak's Science Corporation secured $230 million in Series C funding to commercialize PRIMA, a photovoltaic retinal implant restoring vision for geographic atrophy patients.
German neurotechnology firm CorTec has completed its second human implantation, advancing its position in the competitive brain-computer interface market alongside U.S. rivals.
The neurotechnology company founded by Neuralink co-founder Max Hodak has raised $230 million at a $1.25 billion valuation, bringing its total funding to $489 million as it pushes toward commercialization of its retinal implant.
Max Hodak's neurotechnology company secures major Series C funding as the BCI industry consolidates around clinical applications and commercial viability.
Max Hodak's Science Corporation secures $230 million to commercialize its retinal BCI implant, marking one of the largest funding rounds in neurotechnology as vision restoration approaches clinical reality.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. Unsubscribe anytime. We respect your privacy.